Company intelligence / Profile preview

Hawksmoor Investment Management

Exeter, England, United Kingdomhawksmoornyc.com ↗

Ownership: Private
Development stage: Other

Overview

Hawksmoor Investment Management is a UK-based investment management firm that manages funds and portfolios for private clients and institutions. While the firm invests in healthcare and biotech sectors as part of its diversified strategies—including direct equities and managed funds—it does not itself conduct drug discovery or development. The company’s research highlights trends in genomics, gene editing, telemedicine, and pharma innovation as attractive areas for investment[1][5][6]. Its funds have exposure to large-cap pharmaceutical companies like Novartis and AstraZeneca as well as healthcare innovators such as Stryker[1][5].

Industry: Investors

Partnerships

Apex Fundrock Limited

Beyond the preview

Go deeper on Hawksmoor Investment Management.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hawksmoor Investment Management.

Explore the full profile